Jian Zhou
Chongqing University
4435 Papers
12.1K Citations
Jian Zhou is an academic researcher from Chongqing University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 128, co-authored 3007 publications. Previous affiliations of Jian Zhou include Minzu University of China & Max Planck Society.
Chat about Author
Papers
Recent advances in multicatalyst promoted asymmetric tandem reactions.
TL;DR: The current achievement of this promising field of multicatalyst promoted asymmetric tandem reactions is discussed, including the advantages and difficulties of this research, and the strategies applied to address these problems.
437
A decade's studies on metastasis of hepatocellular carcinoma.
Zhao-You Tang,Sheng-Long Ye,Yinkun Liu,Lun-Xiu Qin,Hui-Chuan Sun,Qin-Hai Ye,Lu Wang,Jian Zhou,Shuang-Jian Qiu,Yan Li,Xue-Ning Ji,Hu Liu,Jing-Ling Xia,Zhi-Quan Wu,Jia Fan,Zeng-Chen Ma,Xin-Da Zhou,Zhi-Ying Lin,Kang-Da Liu +18 more
TL;DR: A molecular signature that can classify metastatic HCC patients is generated, osteopontin is identified as a lead gene in the signature, and it is found that genes favoring metastasis progression were initiated in the primary tumors.
437
Fundamentals of inertial focusing in microchannels
Jian Zhou,Ian Papautsky +1 more
TL;DR: This work describes and experimentally validate a two-stage model inertial focusing in microchannels and proposes a mechanism for elucidation of the equilibration mechanism, ultimately leading to improved performance and broader acceptance of the inertial microfluidic devices in a wide range of applications.
431
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
Qiujin Shen,Jia Fan,Xin-Rong Yang,Yexiong Tan,Weifeng Zhao,Yang Xu,Ning Wang,Yongdong Niu,Zheng Wu,Jian Zhou,Shuang-Jian Qiu,Ying-Hong Shi,Bin Yu,Ning Tang,Wei Chu,Min Wang,Jinhua Wu,Zhigang Zhang,Yang Shengli,Jianren Gu,Hongyang Wang,Hongyang Wang,Wenxin Qin +22 more
TL;DR: DKK1 could complement measurement of AFP in the diagnosis of HCC and improve identification of patients with AFP-negative H CC and distinguish HCC from non-malignant chronic liver diseases.
400
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
Huating Li,Qichen Fang,Fei Gao,Jia Fan,Jian Zhou,Xiaoying Wang,Huizhen Zhang,Xiaoping Pan,Yuqian Bao,Kun-san Xiang,Aimin Xu,Weiping Jia +11 more
TL;DR: The results support the role of FGF21 as a key regulator of hepatic lipid metabolism in humans, and suggest that serum FGF 21 can be potentially used as a biomarker for NAFLD.
397